AXT (NASDAQ:AXTI – Get Free Report) is scheduled to post its quarterly earnings results after the market closes on Thursday, May 2nd. Analysts expect AXT to post earnings of ($0.08) per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.
AXT (NASDAQ:AXTI – Get Free Report) last posted its quarterly earnings results on Thursday, February 22nd. The semiconductor company reported ($0.09) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.05. AXT had a negative net margin of 23.59% and a negative return on equity of 7.80%. The company had revenue of $20.43 million during the quarter, compared to the consensus estimate of $17.62 million. On average, analysts expect AXT to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
AXT Trading Down 1.0 %
AXTI stock opened at $3.00 on Wednesday. The firm has a 50 day moving average of $4.00 and a 200-day moving average of $2.92. AXT has a 12-month low of $1.89 and a 12-month high of $5.64. The company has a market cap of $132.75 million, a price-to-earnings ratio of -6.98 and a beta of 2.24.
Analysts Set New Price Targets
Get Our Latest Stock Report on AXTI
AXT Company Profile
AXT, Inc designs, develops, manufactures, and distributes compound and single element semiconductor substrates. The company offers indium phosphide for use in data center connectivity using light/lasers, high-speed data transfer in data centers, 5G communications, fiber optic lasers and detectors, consumer devices, passive optical networks, silicon photonics, photonic integrated circuits, thermo-photovoltaics, RF amplifier and switching, infrared light-emitting diode (LEDS) motion control, lidar for robotics and autonomous vehicles, and infrared thermal imaging.
Recommended Stories
- Five stocks we like better than AXT
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- 3 REITs to Buy and Hold for the Long Term
- Hilton Demonstrates Asset Light is Right for Investors
- How to Capture the Benefits of Dividend Increases
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for AXT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXT and related companies with MarketBeat.com's FREE daily email newsletter.